ASBP vs ASMB

Aspire Biopharma Holdings, Inc. vs Assembly Biosciences, Inc. — Valuation Comparison 2026

ASBP

Biotechnology
Aspire Biopharma Holdings, Inc.
Quality
4.6
out of 10
Value Trap
22
SAFE
Price
$5.53
Last close
Models
8/13
Active
VS

ASMB

Biotechnology
Assembly Biosciences, Inc.
Quality
6.1
out of 10
Value Trap
18
SAFE
Price
$27.73
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType ASBP Fair ValueASBP Upside ASMB Fair ValueASMB Upside
Bayesian DCF Intrinsic $3.92 -29.0% $6.31 -77.3%
First Chicago Scenario $4.48 -19.8% $5.49 -80.2%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $7.61 +37.6% $27.52 -0.7%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ASBP vs ASMB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ASBP vs ASMB — Which Stock Is More Undervalued?

ASMB scores higher with a 6.1/10 quality rating vs ASBP's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aspire Biopharma Holdings, Inc. (ASBP) and Assembly Biosciences, Inc. (ASMB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ASBP currently trades at $5.53 with a QOC of 4.6/10, while ASMB trades at $27.73 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).